Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9932, pp. 1899 - 1911
Summary Background The associations of blood pressure with the different manifestations of incident cardiovascular disease in a contemporary population have...
Internal Medicine | Risk Assessment - methods | Age Distribution | Follow-Up Studies | Humans | Middle Aged | Hypertension - drug therapy | Male | Angina Pectoris - etiology | Aortic Aneurysm, Abdominal - epidemiology | Incidence | England - epidemiology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Angina Pectoris - epidemiology | Female | Blood Pressure - physiology | Hypertension - epidemiology | Medical Record Linkage | Subarachnoid Hemorrhage - epidemiology | Cardiovascular Diseases - etiology | Acute Disease | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Intracranial Hemorrhage, Hypertensive - epidemiology | Hypertension - complications | Subarachnoid Hemorrhage - etiology | Aged | Chronic Disease | Aortic Aneurysm, Abdominal - etiology | Blood pressure | Research | Cardiovascular diseases | Analysis | Studies | Medical research | Cardiovascular disease | Health risk assessment
Internal Medicine | Risk Assessment - methods | Age Distribution | Follow-Up Studies | Humans | Middle Aged | Hypertension - drug therapy | Male | Angina Pectoris - etiology | Aortic Aneurysm, Abdominal - epidemiology | Incidence | England - epidemiology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Angina Pectoris - epidemiology | Female | Blood Pressure - physiology | Hypertension - epidemiology | Medical Record Linkage | Subarachnoid Hemorrhage - epidemiology | Cardiovascular Diseases - etiology | Acute Disease | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Intracranial Hemorrhage, Hypertensive - epidemiology | Hypertension - complications | Subarachnoid Hemorrhage - etiology | Aged | Chronic Disease | Aortic Aneurysm, Abdominal - etiology | Blood pressure | Research | Cardiovascular diseases | Analysis | Studies | Medical research | Cardiovascular disease | Health risk assessment
Journal Article
Lancet Diabetes & Endocrinology, The, ISSN 2213-8587, 2015, Volume 3, Issue 2, pp. 105 - 113
Summary Background The contemporary associations of type 2 diabetes with a wide range of incident cardiovascular diseases have not been compared. We aimed to...
Endocrinology & Metabolism | Other | Follow-Up Studies | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cardiovascular Diseases - complications | Cardiovascular Diseases - epidemiology | Adult | Female | Aged | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Databases, Factual
Endocrinology & Metabolism | Other | Follow-Up Studies | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cardiovascular Diseases - complications | Cardiovascular Diseases - epidemiology | Adult | Female | Aged | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Databases, Factual
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9925, pp. 1305 - 1312
Summary Background International research for acute myocardial infarction lacks comparisons of whole health systems. We assessed time trends for care and...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | ACC/AHA GUIDELINES | MANAGEMENT | COUNTRIES | STRATEGY | ASSOCIATION TASK-FORCE | REPERFUSION THERAPY | MORTALITY-RATES | FOCUSED UPDATE | DENMARK | Myocardial Infarction - therapy | Myocardial Infarction - mortality | Humans | Risk Factors | Survival Analysis | Female | Male | Registries | Aged | Sweden - epidemiology | United Kingdom - epidemiology | Care and treatment | Diagnosis | Research | Patient outcomes | Heart attack | Transluminal angioplasty | Medical research | Sweden | Heart beat | Analysis | Mortality | Health care reform | Medicine, Experimental | United Kingdom | Diabetes | Cardiology | Heart attacks | Coronary vessels | Clinical outcomes | Intervention | Myocardial infarction | Subgroups | Calcium-binding protein | Blood pressure | Trends | Anticoagulants | Health | Diabetes mellitus | Glycoproteins | Patients | Survival | Health care delivery | Heart rate | International comparisons | Studies | Troponin | Hospitals | Lungs | Fatalities | Infarction | Acute coronary syndromes | Smoking | Medical and Health Sciences | Medicin och hälsovetenskap
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | ACC/AHA GUIDELINES | MANAGEMENT | COUNTRIES | STRATEGY | ASSOCIATION TASK-FORCE | REPERFUSION THERAPY | MORTALITY-RATES | FOCUSED UPDATE | DENMARK | Myocardial Infarction - therapy | Myocardial Infarction - mortality | Humans | Risk Factors | Survival Analysis | Female | Male | Registries | Aged | Sweden - epidemiology | United Kingdom - epidemiology | Care and treatment | Diagnosis | Research | Patient outcomes | Heart attack | Transluminal angioplasty | Medical research | Sweden | Heart beat | Analysis | Mortality | Health care reform | Medicine, Experimental | United Kingdom | Diabetes | Cardiology | Heart attacks | Coronary vessels | Clinical outcomes | Intervention | Myocardial infarction | Subgroups | Calcium-binding protein | Blood pressure | Trends | Anticoagulants | Health | Diabetes mellitus | Glycoproteins | Patients | Survival | Health care delivery | Heart rate | International comparisons | Studies | Troponin | Hospitals | Lungs | Fatalities | Infarction | Acute coronary syndromes | Smoking | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, pp. S86 - S86
Abstract Background The contemporary associations of type 2 diabetes with a wide range of incident cardiovascular diseases have not been compared. Previous...
Internal Medicine | Heart failure | Type 2 diabetes | Medical research | Analysis | Medicine, Experimental | Heart attack | Medical informatics
Internal Medicine | Heart failure | Type 2 diabetes | Medical research | Analysis | Medicine, Experimental | Heart attack | Medical informatics
Journal Article
The Lancet, ISSN 0140-6736, 08/2019, Volume 394, Issue 10199, pp. 663 - 671
Worldwide treatment recommendations for lowering blood pressure continue to be guided predominantly by blood pressure thresholds, despite strong evidence that...
MORTALITY | TARGET | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | VALIDATION | RISK | HYPERTENSION | Health care | Hypertension | Research & development--R&D | Medical treatment | Medical services | Health risks | Pressure reduction | Cardiovascular disease | Statistics | Patients | Studies | Strategy | Blood pressure | Cardiovascular diseases | Cardiology | Mercury
MORTALITY | TARGET | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | VALIDATION | RISK | HYPERTENSION | Health care | Hypertension | Research & development--R&D | Medical treatment | Medical services | Health risks | Pressure reduction | Cardiovascular disease | Statistics | Patients | Studies | Strategy | Blood pressure | Cardiovascular diseases | Cardiology | Mercury
Journal Article
Heart, ISSN 1355-6037, 07/2017, Volume 103, Issue 13, pp. 982 - 986
In the 2016 update of the stable chest pain guideline, the National Institute for Health and Care Excellence (NICE) has made radical changes to the diagnostic...
Advanced cardiac imaging | Cardiac computer tomographic (CT) imaging | Chronic coronary disease | PROBABILITY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | STRESS ECHOCARDIOGRAPHY | PERFORMANCE | CARDIAC MAGNETIC-RESONANCE | COMPUTED-TOMOGRAPHY ANGIOGRAPHY | OUTCOMES | CORONARY-ARTERY-DISEASE | ACCURACY | Academies and Institutes | Diagnosis, Differential | Chest Pain - etiology | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Humans | England | Diagnostic Techniques, Cardiovascular - standards | Chest Pain - diagnosis | Practice Guidelines as Topic | Usage | Diagnosis | Angiography | Chest pain | Heart | Clinics | Medical imaging | Mortality | Tariffs | Diagnostic tests | Cardiovascular disease | Angina pectoris | Patients | Pain | Medical prognosis | Coronary vessels | Tomography | Acute coronary syndromes
Advanced cardiac imaging | Cardiac computer tomographic (CT) imaging | Chronic coronary disease | PROBABILITY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | STRESS ECHOCARDIOGRAPHY | PERFORMANCE | CARDIAC MAGNETIC-RESONANCE | COMPUTED-TOMOGRAPHY ANGIOGRAPHY | OUTCOMES | CORONARY-ARTERY-DISEASE | ACCURACY | Academies and Institutes | Diagnosis, Differential | Chest Pain - etiology | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Humans | England | Diagnostic Techniques, Cardiovascular - standards | Chest Pain - diagnosis | Practice Guidelines as Topic | Usage | Diagnosis | Angiography | Chest pain | Heart | Clinics | Medical imaging | Mortality | Tariffs | Diagnostic tests | Cardiovascular disease | Angina pectoris | Patients | Pain | Medical prognosis | Coronary vessels | Tomography | Acute coronary syndromes
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 02/2006, Volume 60, Issue 2, pp. 222 - 228
Summary Heart rate, a major determinant of angina in coronary disease, is also an important predictor of cardiovascular mortality. Lowering heart rate is...
If current | heart rate | Ivabradine | angina | If channel | Heart rate | channel | current | Angina | Drug Focus
If current | heart rate | Ivabradine | angina | If channel | Heart rate | channel | current | Angina | Drug Focus
Journal Article
Heart, ISSN 1355-6037, 07/2017, Volume 103, Issue 13, pp. 995 - 1001
BackgroundIn patients with suspected angina pectoris, CT coronary angiography (CTCA) clarifies the diagnosis, directs appropriate investigations and therapies,...
STABLE ANGINA | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | PECTORIS | NONCARDIAC CHEST-PAIN | DISEASE | ACCEPTANCE | PERFUSION | COMPUTED-TOMOGRAPHY | Reproducibility of Results | Prospective Studies | Follow-Up Studies | Angina Pectoris - diagnosis | Humans | Middle Aged | Male | Angina Pectoris - etiology | Coronary Disease - diagnosis | Angina Pectoris - psychology | Young Adult | Computed Tomography Angiography - methods | Coronary Angiography - methods | Coronary Disease - complications | Adolescent | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Heart | Pain | Medical imaging | Coronary vessels | Tomography | Patient satisfaction | Angina pectoris | Cardiology | Quality of life | 1507 | Coronary Artery Disease | 1506
STABLE ANGINA | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | PECTORIS | NONCARDIAC CHEST-PAIN | DISEASE | ACCEPTANCE | PERFUSION | COMPUTED-TOMOGRAPHY | Reproducibility of Results | Prospective Studies | Follow-Up Studies | Angina Pectoris - diagnosis | Humans | Middle Aged | Male | Angina Pectoris - etiology | Coronary Disease - diagnosis | Angina Pectoris - psychology | Young Adult | Computed Tomography Angiography - methods | Coronary Angiography - methods | Coronary Disease - complications | Adolescent | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Heart | Pain | Medical imaging | Coronary vessels | Tomography | Patient satisfaction | Angina pectoris | Cardiology | Quality of life | 1507 | Coronary Artery Disease | 1506
Journal Article
Heart, ISSN 1355-6037, 12/2012, Volume 98, Issue 23, pp. 1722 - 1727
Aim Primary percutaneous coronary intervention (PPCI) produces more effective coronary reperfusion and allows immediate risk stratification compared with...
STREPTOKINASE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | PRIMARY ANGIOPLASTY | Myocardial Infarction - diagnosis | Myocardial Infarction - epidemiology | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Feasibility Studies | Hospital Mortality - trends | Coronary Angiography | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Patient Discharge - standards | Female | Aged | London - epidemiology | Percutaneous Coronary Intervention | Transluminal angioplasty | Care and treatment | Patient outcomes | Hospital utilization | Research | Heart attack | Length of stay | Heart failure | Costs | Stroke | Heart attacks | Hospitals | Mortality | Emergency medical care | Acute coronary syndromes | Patients | Data bases | Veins & arteries
STREPTOKINASE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | PRIMARY ANGIOPLASTY | Myocardial Infarction - diagnosis | Myocardial Infarction - epidemiology | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Feasibility Studies | Hospital Mortality - trends | Coronary Angiography | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Patient Discharge - standards | Female | Aged | London - epidemiology | Percutaneous Coronary Intervention | Transluminal angioplasty | Care and treatment | Patient outcomes | Hospital utilization | Research | Heart attack | Length of stay | Heart failure | Costs | Stroke | Heart attacks | Hospitals | Mortality | Emergency medical care | Acute coronary syndromes | Patients | Data bases | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 8, pp. 723 - 732
In this randomized, double-blind trial involving patients with type 2 diabetes at high risk for cardiovascular events, basal insulin degludec was noninferior...
VARIABILITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | BASAL INSULIN | HYPOGLYCEMIA | RISK | COMPLICATIONS | OUTCOMES | INSULIN GLARGINE | Hypoglycemic Agents - therapeutic use | Insulin Glargine - adverse effects | Blood Glucose - analysis | Double-Blind Method | Humans | Middle Aged | Insulin Glargine - therapeutic use | Kaplan-Meier Estimate | Male | Incidence | Insulin, Long-Acting - adverse effects | Diabetes Mellitus, Type 2 - blood | Insulin, Long-Acting - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Care and treatment | Insulin glargine | Research | Drug testing | Adolescence | Fasting | Diabetes mellitus | Clinical trials | FDA approval | Glucose | Hypoglycemia | Patients | Insulin | Studies | Diabetes | Children | Health risk assessment | Drug dosages
VARIABILITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | BASAL INSULIN | HYPOGLYCEMIA | RISK | COMPLICATIONS | OUTCOMES | INSULIN GLARGINE | Hypoglycemic Agents - therapeutic use | Insulin Glargine - adverse effects | Blood Glucose - analysis | Double-Blind Method | Humans | Middle Aged | Insulin Glargine - therapeutic use | Kaplan-Meier Estimate | Male | Incidence | Insulin, Long-Acting - adverse effects | Diabetes Mellitus, Type 2 - blood | Insulin, Long-Acting - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Care and treatment | Insulin glargine | Research | Drug testing | Adolescence | Fasting | Diabetes mellitus | Clinical trials | FDA approval | Glucose | Hypoglycemia | Patients | Insulin | Studies | Diabetes | Children | Health risk assessment | Drug dosages
Journal Article